FINWIRES · TerminalLIVE
FINWIRES

Stifel Canada维持对NexGen Energy的“买入”评级，该公司已完成冬季钻探；目标价维持在12.00加元。

-- 周四，Stifel Canada维持对NexGen Energy（NXE.TO）股票的“买入”评级和30.00加元的目标价。此前，该公司已结束了位于萨斯喀彻温省北部帕特森走廊东部铀矿项目的冬季钻探计划。 NexGen公司宣布已完成其在帕特森走廊东部（PCE）矿区的2026年冬季钻探计划，重点展示了高品位矿体垂直方向扩展33%至550米（从412米扩展至210米）。主要成果包括RK-26-271c1（12.6米>10,000cps，2.3米>61,000cps）和RK-26-280c1（4.2米>10,000cps），这两个钻孔在地下834米处发现了矿化。此外，在东南方向600米处发现了一条独立的平行矿化带，表明PCE矿体可能重复出现，与Arrow矿区的多剪切构造相似。值得注意的是，PCE矿区（位于Rook 1矿区以东3.5公里处）的早期钻探表明存在一个与Arrow矿区类似的大型高品位矿体，这可能是NexGen公司目前尚未充分重视的亮点之一。分析师拉尔夫·普罗菲蒂写道：“这为公司发展奠定了基础，并为其在Arrow公司之外的长期增长前景提供了支撑。我们目前假设PCE矿产库存价值为每股2.95美元（1.55亿磅，单价10美元/磅），基于630万吨、品位1.12%的U3O8（截断品位0.01%）。我们重申买入评级。” （报道北美、亚洲和欧洲主要银行及研究机构的股票、大宗商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）

Price: $17.77, Change: $-0.12, Percent Change: -0.67%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB